Cargando…
Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019
This economic evaluation study assesses the clinical benefit of novel drugs approved in 2018 and 2019 and examines whether drugs approved with special regulatory designations appear to provide meaningful therapeutic value.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987900/ https://www.ncbi.nlm.nih.gov/pubmed/35385091 http://dx.doi.org/10.1001/jamanetworkopen.2022.6479 |
| _version_ | 1784682844205875200 |
|---|---|
| author | Vokinger, Kerstin N. Hwang, Thomas J. Glaus, Camille E. G. Kesselheim, Aaron S. |
| author_facet | Vokinger, Kerstin N. Hwang, Thomas J. Glaus, Camille E. G. Kesselheim, Aaron S. |
| author_sort | Vokinger, Kerstin N. |
| collection | PubMed |
| description | This economic evaluation study assesses the clinical benefit of novel drugs approved in 2018 and 2019 and examines whether drugs approved with special regulatory designations appear to provide meaningful therapeutic value. |
| format | Online Article Text |
| id | pubmed-8987900 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Medical Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89879002022-04-22 Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019 Vokinger, Kerstin N. Hwang, Thomas J. Glaus, Camille E. G. Kesselheim, Aaron S. JAMA Netw Open Research Letter This economic evaluation study assesses the clinical benefit of novel drugs approved in 2018 and 2019 and examines whether drugs approved with special regulatory designations appear to provide meaningful therapeutic value. American Medical Association 2022-04-06 /pmc/articles/PMC8987900/ /pubmed/35385091 http://dx.doi.org/10.1001/jamanetworkopen.2022.6479 Text en Copyright 2022 Vokinger KN et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
| spellingShingle | Research Letter Vokinger, Kerstin N. Hwang, Thomas J. Glaus, Camille E. G. Kesselheim, Aaron S. Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019 |
| title | Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019 |
| title_full | Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019 |
| title_fullStr | Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019 |
| title_full_unstemmed | Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019 |
| title_short | Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019 |
| title_sort | therapeutic value assessments of novel medicines in the us and europe, 2018-2019 |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987900/ https://www.ncbi.nlm.nih.gov/pubmed/35385091 http://dx.doi.org/10.1001/jamanetworkopen.2022.6479 |
| work_keys_str_mv | AT vokingerkerstinn therapeuticvalueassessmentsofnovelmedicinesintheusandeurope20182019 AT hwangthomasj therapeuticvalueassessmentsofnovelmedicinesintheusandeurope20182019 AT glauscamilleeg therapeuticvalueassessmentsofnovelmedicinesintheusandeurope20182019 AT kesselheimaarons therapeuticvalueassessmentsofnovelmedicinesintheusandeurope20182019 |